If you are in your 40s or 50s, already taking something for your mood, and now thinking about a GLP-1 for weight, you are asking a more layered question than it looks
Whilst GLP-1 receptor agonists primarily work by enhancing insulin secretion rather than directly improving insulin sensitivity at the cellular level, the associated weight loss that often occurs with these medications can lead to secondary improvements in insulin resistance
Under cholesterol stimulation, GLP-1-induced AMPK activation inhibited PARP-1 activity, therefore attenuating cholesterol-induced toxicity in INS-1 cells
Over time, that burden can contribute to what scientists call oxidative stress, a process that occurs when the production of free radicals outpaces the body's ability to neutralize them
The latter is a ghrelin mimetic that works along a different pathway to CJC-1295, binding to ghrelin receptors and also stimulating the release of GH